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CONTROLLED BIOMINERALIZATION TOWARDS TISSUE ENGINEERING USING 
GENTICALLY ENGINEERED HYDROXYAPATITE BINDING PEPTIDES 
SUMMARY 
Hydroxyapatite is the principal mineral of mammalian hard tissues, such as bone and teeth. 
Hydroxyapatite particles are found in various shapes and sizes in different tissues providing 
the specific functional properties of the tissues. Many proteins in bone and dental matrices 
are involved in the formation of the hydroxyapatite crystallites and their growth into myriad 
different nano and micro-architectures. These proteins affect hydroxyapatite formation at 
different times during the tissue generation and spatial locations in the tissue leading to the 
differences in the molecular composition, structure and self-assembly properties of 
hydroxyapatite.  
Because of the enormous number of large proteins involved in the tissue generation and the 
current problems associated with the difficulties of quantifying their spatial and temporal 
distribution, we launched, first, to select genetically engineered polypeptides that have 
specific affinity to HA, and then investigate how hydroxyapatite binding peptides affect HA 
formation. We have combinatorially selected hydroxyapatite binding peptides via a 
commercial M13 C7C library. Binding characterization of the peptides was done via 
fluorescence microscopy and ELISA. The strongest binding clone, MG-49 and a weak 
binding clone, MG-63, were selected and the peptide sequence they display was 
commercially synthesized to study their effects in an AP mediated in vitro mineralization 
system. We observed that MG-49 inhibits nucleation of octacalcium phosphate, a precursor 
of hydroxyapatite, while it promotes the crystal growth compared to control and weak binding 
peptides. Kinetic analysis showed that MG-49 peptide shows its effect on crsytal morphology 
by controlling the reaction kinetics. 
Combinatorially selected HA binding peptides may also find use in several different fields, 
such as bioinformatics, medical biomaterials and drug delivery applications in addition to 
hard tissue engineering. 
 xiii
GENETİK MÜHENDİSLİĞİ İLE ELDE EDİLEN, HİDROKSİAPATİTE BAĞLANAN 
PEPTİDLER İLE DOKU MÜHENDİSLİĞİNE YÖNELIK KONTROLLÜ 
BİYOMİNERALİZASYON 
ÖZET 
Hidroksiapatit, kemik ve diş gibi memeli sert dokularının birincil mineralidir. Hidroksiapatit 
parçacıkları vücutta farklı boyutlarda ve şekillerde bulunabilir. Bu farklı şekil ve boyutlar 
dokuların özgün işlevsel özelliklerini belirler. Diş ve kemik dokularında hidroksiapatit 
oluşumunda ve farklı mikro ve nano mimariler oluşturmasında rol alan birçok protein bulunur. 
Bu proteinler hidroksiapatit oluşumunu doku gelişimi sırasında farklı yerlerde ve zamanlarda 
etkileyerek farklı moleküler bileşimlerde ve yapılarda hidroksiapatit oluşumunu sağlarlar.  
Doku gelişiminde rol alan proteinlerin sayısının çok fazla olmasından ve proteinlerin 
zamansal ve mekansal dağılımlarının belirlenmesindeki zorluklardan dolayı, bu çalışmada ilk 
önce genetik mühendisliği ile hidroksiapatite özgün olarak bağlanan peptidler seçip, daha 
sonra bu peptidlerin hidroksiapatit oluşumunu nasıl etkilediğini inceleme yolunu seçtik. 
Hidroksiapatite özgün olarak bağlanan peptidler ticari bir kütüphane olan M13 C7C 
kütüphanesi aracılığı ile seçildi. Peptidlerin bağlanma özellikleri flüoresan mikroskopisi ve 
ELISA yöntemleri ile karakterize edildi. Karakterizasyon sonucunda en kuvvetli bağlanan klon, 
MG-49, ve zayıf bağlanan bır klon, MG-63, seçilerek mineralizasyon çalışmaları için peptid 
dizileri ticari olarak sentezlendi. Mineralizasyon çalışmaları için Alkalin Fosfataz aracılıklı bir 
mineralizasyon sistemi kullanıldı. Mineralizasyon çalışmaları MG-49 peptidinin, 
hidroksiapatitin bir öncülü olan oktakalsiyum fosfat nükleasyonunu baskıladığı fakat 
kristallerin büyümesini tetiklediğini gösterdi. Tepkime kinetiği analizleri MG-49 peptidinin 
kristallerin morfolojilerinde oluşturduğu etkisini tepkime kinetiğini kontrol ederek gösterdiğini 
ortaya koydu.  
Kombinasyonel olarak seçilen hidroksiapatite bağlanan peptidler, malzemeye yüksek 
özgünlük, seçicilik ve bağlanma özellikleri gösterebildiklerinden yalnızca sert doku 
mühendisliğinde degil, biyo-bilişim, biyo-uyumlu yüzeylerin, biyo-malzemelerin 
oluşturulmasında ve kontrollü ilaç salınımı gibi farklı alanlarda da kullanılabilir. 
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1. INTRODUCTION AND BACKGROUND 
1.1. The Importance of Proteins in Biomineralization 
The regulated formation of inorganic minerals in living systems is called 
biomineralization. The ability to deposit minerals in living organisms serves for 
various purposes. It is most important for the formation and proper shaping of hard 
parts, such as bone, teeth and seashells. The mineral deposits are also used by 
organisms for maintaining homeostatic cellular levels of inorganic ions. For plants, 
mineral crystals such as calcium oxalate crystals can also be used for defense. A 
great variety of organisms posses the ability to deposit minerals. For example, 
magnetotactic bacteria deposit magnetite (Fe3O4) or greigite (Fe3S4) crystals 
enclosed in organic sheaths, Blakemore (1975), mollusks form calcite crystals in 
their shells, Weiner et al. (1976), diatoms form a highly silicified cell wall, Reimann 
and Lewin (1964), some cactus plants form calcium oxalate crystals, Gibson and 
Horak (1978) and vertebrates generate apatite crystals, found in bone and teeth 
(Lowenstam and Weiner, 1989). (Figure 1.1.) 
The main difference between biogenic and synthetic mineral deposits is that the 
mineralization process in living organisms is strictly regulated by a specific set of 
biomolecules, typically by proteins, while only a limited control can be established 
over the properties of synthetic materials. Proteins (also proteolipids and 
proteoglycans), regulate the balance between crystal saturation and precipitation in 
solution, inhibition or promotion of nucleation and growth of mineral crystals and the 
overall structure and the assembly of the crystal (Lowenstam and Weiner, 1989) 
The proteins regulating the biomineralization processes are studied generally under 
two main classes; acidic proteins and framework proteins. Acidic proteins are 
named as such because their function is intimately connected to their acidic nature 
and abundance of polar side chains that are negatively charged at neutral pH. 
Typically, acidic proteins are rich in aspartate, glutamate, phosphorylated serine, 
tyrosine, and threonine. In vertebrates, these acidic proteins are found in bone, 
salivary fluids, and the urinary tract and bladder (Long et al, 1998). These proteins 
may also be covalently bonded to polysaccharides, which are rich in carboxylate, to 
 1
form acidic proteoglycans. The acidic proteins are intimately associated with the 
mineral and regulate mineral formation. (Long et al, 1998) 
The second type of proteins involved in biomineralization is the framework proteins. 
The function of framework proteins is true to their name. They serve as scaffolds for 
mineral deposits, and they tend to be insoluble, relatively hydrophobic and are 
typically cross-linked. Collagen, found in bone tissue, is an excellent example of a 
framework protein, because its long, α-helix shape, with three interwoven strands, is 
very robust and provides shape to the crystalline tissue (Lowenstam and Weiner, 
1989). 
 
 
e
 
 
 
 
Figure1.1: Examples of biogenic minerals: a) SEM image of single crystalline, 
single domained and crystallographically aligned magnetite nanoparticles formed by 
A. magnetotacticum. (Inset: TEM image) b) SEM image of a growth edge of abalone 
(Haliotis rufescens) displaying aragonite platelets (blue) separated by organic films 
(orange) that eventually becomes nacre (inset: TEM) image) c) SEM image of highly 
ordered hydroxyapatite crystallites in mouse enamel  (inset: schematic cross-section 
of a human tooth) d) SEM image of silica layers of the sponge spicule of Rosell. 
(Schematic illustration of the cross-shaped apex) (a-d: Sarikaya et al, 2003) (e) SEM 
image of the calcium oxalate particles produced by the Cactus senilis (inset: optical 
microscopy image of the Cactus senilis epidermis. Black features are the calcium 
oxalate crystals. (Gibson and Horak, 1978)  
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1.1.1. Hydroxyapatite: Formation and Proteins 
Hydroxyapatite (HA) is a naturally occurring form of calcium apatite with the formula 
Ca5(PO4)3(OH), but is usually written Ca10(PO4)6(OH)2 to denote that the crystal unit 
cell comprises two molecules. The hydroxyl ion in the structure can be substituted 
by fluoride, chloride or carbonate.  
HA is the principal mineral of mammalian hard tissues, such as bone and teeth. 
(Lowenstam and Weiner, 1989) However, hydroxyapatite particles are found in 
various shapes and sizes in different tissues providing the specific functional 
properties of the tissues. For example, mammalian tooth’s inorganic part is 
composed of three different layers, from top to bottom, enamel, dentin and 
cementum (Lowenstam and Weiner, 1989) (Figure 1.2.). The main constitution of 
these layers is HA. However, each of these tissues possesses unique mechanical 
properties originating from different organizations of HA crystals. Highly ordered HA 
nano-rods in the enamel provide the extraordinary hardness of the tissue (Fong et 
al, 2003). Tubular organization of the dentin provides the teeth the ability to flex and 
absorb tremendous functional loads without fracturing (Kinney et al, 2003). The 
plate like structure of cementum provides the softness of the tissue allowing the 
attachment of the periodontal ligaments (He et al, 2003). 
 
Figure 1.2: SEM image of cross-section of a mouse incisor tooth. Morphological 
differences are clearly seen between (E) Enamel, (C) Cementum and (D) Dentin, 
(inset: i; high magnification of the dentin-cementum junction area. ii; high 
magnification of enamel crystals) (Fong et al, 2003) 
From this standpoint, in vitro fabrication of hydroxyapatite with controlled size, shape 
and properties has been a significant goal in the filed of restorative and regenerative 
biomaterials.  This challenge has been the focus of intensive research for many 
years. There is an enormous amount of literature dealing with the fabrication 
pathways of HA. Synthetic HA particles have been produced by a variety of routes 
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including hydrothermal processing, Mengeot et al. (1973), wet chemical 
precipitation, Lopez-Macipe et al. (1998), Afshar et al. (2003), sol–gel, Layrolle et 
al., (1998),  Deptula et al. (1993), solid state reactions, Verbeerck et al. (1995). 
Other HA synthesis methods, such as microwave irradiation, Lerner et al. (1991), 
spray pyrolysis, Luo et al. (1995), and mechano-chemical treatment, Rhee et al. 
(2002) have also been reported. However, biomimetic approach for the synthesis of 
HA has gained an increasing attention over the last few years since, in contrast to 
the methods listed above; the synthesis is carried out at 37oC, neutral pH and in 
ionic environments similar to those of human body with the biomimetic approach. 
(Tanahashi et al., 1994. Schwarz et al., 1998. Feng et al., 2005). Therefore, this 
synthesis route shares many similar properties with the biological synthesis of HA in 
vertebrate body. 
The mineralization process of vertebrate hard tissues include the synthesis of an 
extra cellular matrix (ECM) by ECM forming cells (ameloblasts, osteoblasts, 
dentinoblasts, etc.) and deposition of minerals within the ECM. The nucleation-
growth kinetics and the morphology of HA are regulated by a specific set of 
biomolecules, called ECM proteins. (Lowenstam and Weiner, 1989). ECM proteins 
are studied under two classes; “collagenous ECM proteins” and “non-collagenous 
ECM proteins” (Lowenstam and Weiner, 1989). 
Collagen is the most abundant organic component of the bone and dentin (50 - 90% 
of protein content). It is also the most abundant protein in human body. Collagen in 
bone and dentin are mainly Type I collagen. Type I collagen in bone is produced 
from the same gene as that in soft tissues (Rich et al, 1961). Therefore, Type I 
collagen in bone is essentially the same molecule as that in non-calcified tissue. The 
difference between bone collagen and non-calcified tissue collagen arise from the 
posttranslational modifications. These modifications include hydroxylation of lysine 
residues, glycosylation of hydroxylysine, and phosphorylation, and are believed to 
play an integral role in collagen mineralization (Kao et al, 1965). From the viewpoint 
of hydroxylation, for example, the extent of hydroxylation of lysine residues is much 
higher in bone collagen than in non-calcified tissue. The extent and site of the 
hydroxylation governs cross-linking patterns, hence, packing of collagen molecules 
(Figure 1.3.). It is noteworthy that the average gap between collagen molecules in 
tendons is smaller than the diameter of phosphate ion, although that in bone is 
larger than that of phosphate ion which enables the phosphate ions migrate into 
collagen fibrils (Rich et al, 1961). 
 4
During the mineralization process, apatite crystals grow preferentially lengthwise in 
the direction of the long axis of collagen and in width along channels or grooves that 
are formed by adjacent hole zones of collagen. Collagen fibers overlap adjacent 
fibers as they repeat every 680 Å. Hole zones are the areas of low-density bone 
collagen and overlap zones are areas of very high-density collagen. Hydroxyapatite 
crystals are arranged in layers within each fiber, resembling overlapping bricks. 
These combined properties, plus the degree of bonding between the collagen fibers 
and the crystals, provide a robust structure that has both extreme tensile and 
compression strength, making the bone, on a weight basis, stronger than concrete. 
However, numerous studies indicate that collagen is not a direct nucleator of apatite 
deposition. Rather, collagen provides a template for mineral deposition which may 
be initiated by associated non-collagenous proteins (Kao et al, 1965).  
 
Figure 1.3: Schematic representation of the molecular arrangement of collagen and 
hydroxyapatite crystals in compact bone. (Kinney et al, 2003)   
Non-collagenous proteins are mostly tissue specific and compose of a small portion 
of the organic part of the hard tissues. (Lowenstam, H.A. 1989). A list of major and 
best characterized non-collagenous proteins influencing mineral formation during 
bone and teeth development are listed in Table 1.1.  
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Table 1.1: List of major non-collagenous proteins influencing HA formation during 
bone and teeth development. Symbols (f) and (i) indicate free and immobilized 
proteins, respectively. 
Protein HA Formation Remarks 
Osteopontin  Inhibits mineralization (Hunter et al,   1996)   
Promotes cell attachment (McKee 
et al, 1996) 
Bone Sialoprotein II Promotes nucleation (Hunter et al,   1993) 
Binds to HA and collagen 
Promotes osteoblast 
differantioation  (Zhou et al, 1995)  
Bone Morphogenic Proteins Embryonic patterning (Chen et al, 2004) Growth Factors (Chen et al, 2004) 
Matrix GLA protein Inhibits mineralization (Luo et al, 1997) 
Binds to HA and Ca+2  (Price  et al, 
1985) 
Osteocalcin ( f ) 
Inhibits mineralization (Price et al, 
1981)  
Inhibits seeded growth  (Romberg et 
al, 1986)  
Inhibits osteoblast activity (Ducy et 
al, 1996)  
Binds to HA, but not to ACP (Price 
et al, 1976)   
Osteocalcin ( i ) Promotes mineralization (Doi et al, 1993) 
Binds to HA (Fujisawa et al, 1991)  
and collagen (Fujisawa et al, 1992) 
Osteonectin ( f )  Inhibits mineralization (Doi et al, 1992) Binds to HA and collagen  (Romberg et al, 1985)  
Osteonectin ( i )  Promotes mineralization (Termine et al, 1981)   
Links HA to collagen (Termine et al, 
1981)  
Dentin phosphoprolyn ( f ) Inhibits mineralization at high concentration (Doi et al, 1992)  
Binds to collagen (Veis, 1993) 
Binds to Ca and PO4 ions (Massh, 
1989)  
Binds to HA (Fujisawa et al, 1991)  
Dentin phosphoprolyn ( i ) Promotes formation mineralization (Doi et al, 1993)   
Amelogenin 
Aligns crystals into parallel arrays 
(Beniasha et al, 2005) 
Modulates cell attachment (Hoang et 
al, 2002) 
Binds to HA (Ryu et al, 1999) 
Statherin Inhibits mineralization (Moreno et al, 1979) 
Binds to mineral (Schlesinger et al, 
1977) 
Enamelin  Inhibits formation (Romberg et al, 1986) 
Binds to mineral (Yanagisawa et al, 
1981) 
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Bone sialoprotein is one of the most important extra cellular matrix proteins in bone. 
It has been showed that BSP message is up-regulated up to over 140 fold in 
osteoblasts as the cultured cells undergo a massive wave of mineralization, and that 
it can promote de novo nucleation of apatite crystals in vitro (Ibaraki et al., 1992). 
The promotional effects of bone sialoprotein on hydroxyapatite formation are due to 
the polyglutamicacid rich region at the N-terminus of the protein. The major cell 
attachment site (RGD) is near the C-terminus in a coil structure, surrounded by 
sulphated tyrosines and separated from the HA-binding region by sites of extensive 
N- and O- linked glycosylation (Ganss et al., 1999).  (Figure 1.4.) 
 
Figure 1.4: Schematic structure of Bone Sialoprotein (Ganss et al, 1999) 
Matrix Gla protein (MGP) has been shown to have a hydroxyapatite binding domain 
(Price et al., 1985). Studies on MGP-deficient mice have shown an increase in the 
ectopic calcification, which suggest that MGP is an inhibitor of spontaneous 
calcification in arteries and the epiphyseal growth plate (Luo et al., 1997).  
Osteocalcin, also known as bone Gla protein (BGP) is exclusively found in bone 
tissue, accounting for 10-20% of the non-collagenous protein content of the bone. 
Osteocalcin contains gamma-carboxyglutamic acid (Gla) and has affinity to calcium 
and hydroxyapatite Gamma-carboxyglutamic acid (Gla) residues (green), 
responsible for Ca+2 binding are at positions 17, 21 and 24 and a disulphide bound 
is present between residues 23 and 29. (Hoang et al., 2003) (Figure 1.5.). A number 
of studies have demonstrated the inhibitory effects of osteocalcin on hydroxyapatite 
formation when it is free in solution, Price et al. (1981) but promoter effects when 
immobilized, Doi et al. (1993), indicating that protein conformation is also important 
in the process of mineralization. In dentin, osteocalcin is a very minor constituent. 
Osteocalcin appears to be more involved in the regulation of bone turnover, 
particularly in the inhibition of hypercalcification.  
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Osteonectin, also known as secreted protein acidic and rich in cysteine (SPARC) or 
basement membrane protein BM-40 binds strongly to hydroxyapatite (Sage et al, 
1989). It modulates attachment of the cells to the mineral with its affinity to other 
ECM proteins including collagen type I, III, V, VIII, Sage et al. (1989) and IV, Mayer 
et al (1991), thrombospondin, Clezardin et al. (1991) and PDGF-AB and PDGF-BB, 
Raines et al. (1992). Osteonectin also binds to and inhibits the spreading of 
endothelial and smooth muscle cells (Sage et al., 1989).  
Although less than 5% of enamel consists of protein, enamelins comprise 2% of all 
enamel protein. The in vivo role of enamelin on enamel formation is still not clear but 
the enamelin proteins appear to be concentrated in areas closely surrounding the 
enamel mineral crystal surfaces, implying an important role in enamel formation 
(Yanagisawa et al., 1981).  
  
Figure 1.5: Simulation of the secondary structure of Osteocalcin. (Hoang et al., 
2003) 
Osteopontin is a single chain acidic glycoprotein. Its N-terminus binds to HA crystals 
and farther down the peptide backbone is an RGD amino acid sequence that binds 
to a cell surface protein (Flores et al., 1992, Gorski, 1991). This RGD sequence 
promotes the nucleation when bound to cell surface by locking the protein in a 
conformation that leaves certain crystal surfaces uninhibited (Gorski, 1991). (Figure 
1.6.) 
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Figure 1.6: A proposed mechanism for osteopontin’s ability to nucleate 
hydroxyapatite crystals and influence on the orientation of crystal growth when 
bound (b) versus inhibiting growth while in solution (a) (Gorski, 1991) 
Dentin phosphophoryn is a dentin-specific protein and also the most abundant non-
collagenous protein in dentin (Dimuzio and Veis, 1978). A histological study of 
dental tissues from Dentinogenesis Imperfecta type II (DGI-II) affected patients has 
shown that the affected tooth is very different in the DGI-II patient as compared with 
the normal dental tissue. In particular, the dentinal tubules in DGI-II are very 
irregular, which could be the result of perturbations in the process of dentin 
formation.  The same study has shown a dramatic difference in the restriction length 
polymorhism patterns (RFLP) of Dentin phosphophoryn-2 gene between the 
affected and normal patients, indicating that indicated that dentin phosphophoryn 
might be a candidate gene in DGI-II. (Thotakura et al, 2000) 
Statherin is one of the most studied and best understood proteins that influence HA 
formation. Statherin is a phosphoprotein found in human parotid and submandibular 
saliva and shows a high affinity to hydroxyapatite (Johnsson et al., 1993). It has 
been showed that statherin prevents unwanted and potentially harmful 
mineralization in the oral cavity by functioning as the inhibitor of HA crystal 
nucleation and crystal growth (Johnsson et al., 1993).  Statherin has a pI of 4.2, and 
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it is negatively charged in biological conditions and all but one of the charged 
residues is present in N-terminus end of the polypeptide, illustrating the importance 
of the N-terminus for HA affinity (Schelsinger et al, 1977). Specifically, the aspartate, 
two phosposerines, and two glutamates located near the N-terminus are essential to 
statherin’s binding affinity for HA crystals. Solution NMR studies have shown that 
Statherin is unstructured in aqueous solution, but it has been found that the N-
terminal fragment adopts a helical conformation upon binding to hydroxyapatite 
(Shaw et al, 2000).  (Figure 1.7.) 
 
Figure 1.7: Schematic illustration showing statherin interacting with the 001 face of 
HA, with calcium ions in white and phosphoserines in purple. (Shaw  et al, 2000). 
Amelogenin is a gene-specific, low-molecular-weight protein found in tooth, 
comprising 90% of all enamel proteins. Although not completely understood, the 
function of amelogenin is believed to be in organizing enamel rods into parallel 
arrays during tooth development (Figure 1.8., 1.9) and regulating the initiation and 
growth of hydroxyapatite crystals during the mineralization of enamel (Ryu et al, 
1999). Amelogenin is synthesized and secreted by ameloblast cells (Figure 1.8 - 1) 
and assemble into nano-sphere structures approximately 20 nm in diameter with an 
anionic surface (Figure 1.8 - 2).  The nanospheres interact electrostatically with the 
elongating surfaces of the enamel crystallites, acting as 20nm spacers that prevent 
crystal-crystal fusions (Figure 1.8 - 3). Enzymes (Proteinase-1) eventually digest 
away the charged surface of the nanosphres, producing hydrophobic nanospheres 
that further assemble and stabilize the growing crystallites. Finally, other enzymes 
degrade the hydrophobic nanospheres, generating amelogenin fragments and other 
unidentified products, which are resorbed by the ameloblasts (Figure 1.8 - 4). As the 
amelogenin nanosphere protection is removed, crystallites thicken and eventually 
may fuse into mature enamel (Figure 1.8 - 5).  
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 Figure 1.8: A hypothetical model for the role of amelogenin in enamel 
biomineralization (Reproduced from Fincham et al., 1999) 
 
Figure 1.9: SEM image showing enamel architecture (a) in dysplastic tissue in 
amelogenesis imperfecta, which is a genetic disorder caused by incompetent 
amelogenin synthesis, compared with (b) a similar region in a normal tooth. Irregular 
arrangement of crystals causes loss of mechanical strength in the enamel (Ryu et 
al., 1999). 
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1.2. Molecular Biomimetics and Applications 
Biomimetics (also known as bionics, biognosis or biomimicry) is the application of 
methods and systems found in nature to the study, design and engineer materials. 
The biological world has long been a source of inspiration for engineering design. 
The popularity of designs that mimic natural systems is due, in large part, to 
advantages in performance. In the past, drawing ideas from nature was limited to 
macroscopic engineering problems (Ball, 2001. Vogel,1999). Advances in analytical 
techniques over the past several decades have opened the door to understanding 
the materials’ structure and properties at the molecular level and have provided a 
better understanding of the potential of the nanotechnology (Ferry and Goodnick, 
1997. Harris, 1999). However, the realization of the full potential of 
nanotechnological systems has so far been limited due to the difficulties in their 
synthesis and subsequent assembly into useful functional structures and devices. 
Even the most advanced conventional micro and nanotechnology processes have 
the limitations of large-scale synthesis of complex nano-scale architectures 
(Sarikaya et al., 2004). The product is so small in quantity and often not reproducible 
because of the nonspecific interactions, uncontrolled agglomeration, uncontrolled 
surface chemistry, and difficulties in multidimensional assembly for the widespread 
use (Harris, 1999). Biomaterials, on the other hand, are highly organized from the 
molecular to the nano- and macro scales, often in a hierarchical manner, with 
complex nano-architectures (Sakiyama-Elbert and Hubbell, 2001. Mayer and 
Sarikaya, 2002). Therefore, the transfer of technology between living organisms and 
synthetic constructs allows us to mimic natural structures at the micro and nano 
scales. This technology transfer is most desirable because evolutionary process’ 
typically forces natural systems to become as highly optimized and efficient as 
possible. Also, biological materials are synthesized in aqueous environments under 
mild physiological conditions, such as neutral pH, room / body temperature, 
atmospheric pressure, while conventional engineering methods involve techniques 
like melting and solidification processes, thermo mechanical treatments, solution / 
vacuum deposition and growth processes requiring stringent conditions such as high 
heat and pressure and often producing toxic byproducts (DeGarmo et al, 1988).  
In the process of synthesis of hard, as well as soft tissues in biological systems, 
proteins play a key role by both collecting and transporting raw materials, self- and 
co-assembling subunits into short- and long-range-ordered nuclei and substrates 
(Sarikaya and Aksay, 1995. Mann, 1996. Lowenstam and Weis, 1989). Whether in 
controlling tissue formation, biological functions or physical performance, proteins 
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are an indispensable part of biological structures and systems. Therefore, a simple 
conclusion is that the next-generation biomimetic engineering systems should 
include proteins in synthesis, assembly or function (Sarikaya, 1999, Seeman and 
Belcher, 2002, Ball, 2001) (Figure 1.10.)  
 
Figure 1.10: Potential uses of GEPI in engineering systems. (a) linkers for 
nanoparticle immobilization, (b) functional molecules that self-assemble on specific 
surfaces, (c) heterofunctional linkers involving two (or more) binding proteins 
adjoining several nanoinorganic units. (Sarikaya et al., 2003). 
1.3. Selection of Inorganic-binding Peptides 
1.3.1. Display Technologies 
A limited number of natural proteins that bind to inorganic materials have been 
successfully identified and isolated up to date. One example of these proteins is the 
ice-binding protein found in many fish species, plants and insects. By binding to ice 
in the internal fluids of the organisms, these proteins control the particle size, 
morphology, or distribution of ice crystals preventing the freezing damage caused by 
the ice crystals (Liou et al., 2000). Several approaches have been utilized in the 
search of inorganic-binding proteins to understand the inorganic-protein interactions 
with the intent to exploit this knowledge in producing biocompatible materials. 
One approach used to obtain inorganic binding proteins is extracting and purifying 
proteins directly from hard tissues and cloning the genes coding them (Cariolou and 
Morse, 1988). This approach is a straightforward approach to obtain inorganic 
binding proteins but adverse consequences of this approach are that hard tissues 
contain a great number of proteins (Paine and Snead, 1996) and extraction and 
purification process’ of the proteins may be extremely time consuming.  
Another approach is designing inorganic-binding proteins by using theoretical 
molecular approach (Schonburn et al., 2002). In this technique, the amino acid 
sequence and structure of the proteins are predicted by computational biology. This 
approach may be less expensive than other approaches however our little 
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knowledge about the number and structure of the proteins involved in the synthesis 
of biogenic materials makes theoretical design an impractical and time consuming 
approach. 
Combinatorial biology, on the other hand, is an emerging field in design of inorganic 
binding proteins (Pelletier and Sidhu, 2001). In the combinatorial approach, a 
randomized pool of amino acid sequences is created and displayed on the surface 
of a host organism by genetic engineering. Then a target substrate is exposed to the 
randomized library. After removing the non-specific or weak binders with washing 
steps, specific and strong binders are recovered from the target substrate and 
sequenced. “Phage Display” and “Cell Surface Display” are two techniques widely 
used in vitro combinatorial biology techniques (Lee et al., 2003. Smith and Petrenko, 
1997). These techniques have been first developed to explore the interactions 
between organic molecules (Smith, 1985), however have been adapted to explore 
the organic - inorganic interactions, providing a tool for selection of inorganic binding 
peptides  (Sarikaya, 1999. Mao et al., 2003. Brown, 1992). Up to date, phage 
display has been successfully employed by several groups to identify peptides that 
are specific to gallium arsenide, Whaley et al. (2000), silica, Naik et al. (2002a), 
silver, Naik et al. (2002b), zinc sulfide, Lee et al. (2002), calcite, Li et al. (2002), 
cadmium sulfide, Mao et al. (2003), titanium, Sano et al. (2005) and carbon 
nanotubes, Wang et al. (2003). Cell surface display also has been applied to identify 
the iron oxide, gold (Brown, 1992), zinc oxide, zeolites and cuprous oxide, Nygaard 
et al. (2002), binding peptides.  
1.3.2. Phage Display 
Phage display has first been developed by G. Smith to explore the interactions 
between organic molecules (Smith, 1985). Phage display involves the expression of 
random amino acid sequences on coat proteins of the phage. Randomized DNA 
fragment encoding the random amino acid sequence is inserted to one of the 
permissive sites of the phage coat protein (Figure 1.13.), resulting in the phage 
particle to display the encoded peptide on the coat protein and contain its gene in 
the genome. This allows identifying the selected clones simply by DNA sequencing 
(Figure 2.4.). 
Various vectors are used as vehicles for phage display. The first developed vehicle, 
filamentous bacteriophage M13 (Ff family), is the most widely used (Smith, 1985). 
This is due to ease of manipulating phage genome and obtaining high titers of 
phage (1011-12 phages particles per milliliter). Besides these advantages, filamentous 
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phage vehicles have some drawbacks regarding to the size of the displayed peptide. 
The infection of the cell by the filamentous phage is a complex process involving the 
entry of the phage particle into the cell through the cell membrane. The phage g3p 
second N-terminal domain (N2) interacts with the F-pilus on the outside of the 
bacteria (Figure 1.12.a). After F-pilus retraction, the first N-terminal domain of g3p 
(N1) binds to the C-terminal domain of bacterial TolA (TolAIII) (Figure 1.12.b). The 
retracting pilus brings phage g3p domains in closer contact with TolA domains. As a 
consequence, the TolA can assume a more compact state of assembly, thus 
bringing the outer and inner membranes of the bacteria closer together (Figure 
1.12.c). The phage g3p is inserted into the inner membrane, and the cap of the 
phage head is opened to allow phage DNA to enter the bacteria. (Figure 1.12.d) 
(Karlsson et al., 2003). Whereas these limitations interfere with the properties of 
desired protein to be expressed, phage λ, T7 or T4 can be preferred to display 
peptides with various sizes. Although there are some studies on λ, T7 or T4 phage-
based display systems, they are not yet used in a routine way. (Hoess, 2002. 
Danner and Belasco 2001). 
 
Figure 1.11: Schematic illustration of the structure of M13 bacteriophage (adapted 
from Smith and Petrenko, 1997) 
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Figure 1.12: Model for the early events in the phage infection of E. coli. (Karlsson et 
al., 2003) 
 
 
Figure 1.13: Computer simulation of the g3p protein of M13 with the displayed 
peptide on it. 
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1.4. Aim of the Study 
In this study our aim has two aspects. The first aspect is to select hydorxyapatite 
(HA) binding peptides by phage display method using a 7 amino acid constrained 
Phage-Peptide Library. This includes a detailed analysis of the selected sequences 
in terms of physico-chemical properties, binding strength and specificity which would 
lead to obtain the best binders capable of biomimetic applications. The second 
aspect of our study is to investigate the possible effects of the selected 
hydroxyapatite binders on in vitro Ca-P mineral synthesis under biological 
conditions. 
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2. MATERIALS AND METHODS  
2.1. Materials 
2.1.1. Bacterial Strain 
E.coli ER2738, F´ lacIq ∆(lacZ)M15 proA+B+ zzf::Tn10(TetR)/fhuA2 supE thi Δ(lac-
proAB) Δ(hsdMS-mcrB)5 (rk – mk – McrBC–) was used as host strain of M13KE 
bacteriophage. This strain is not a competent strain and it was included as 50 % 
glycerol culture in the Ph.D.-C7C Phage Display Peptide Library Kit, (2003). 
 
1μm
Figure 2.1: TEM image of a single E.coli ER2738 cell at 24,000X magnification. 
(Stained with 2% Ammonium Molybdate) 
2.1.2. Phage - Peptide Library  
Commercailly available Ph.D.-C7C™ Phage Display Peptide Library Kit (New 
England BioLabs Inc., USA) was used for the selection of HA binding peptides. The 
library is produced by displaying random constrained heptapeptides on the pIII coat 
protein of M13KE phage. The library is supplied in 100 µl TBS and 50 % glycerol, 
with 1.5 x 1013 pfu/ml. The libraries complexity is ~ 2.7 x 109. The library was 
purchased within Ph.D.-C7C™ Phage Display Peptide Library Kit, Catalog 
#E8100S.  
M13KE is a derivative of M13mp19 designed for expression of peptides as N-
terminal pIII fusions in phage display applications (Zwick et al. 1998). Relative to the 
parent M13mp19, Acc65 I/Kpn I and Eag I sites have been introduced flanking the 
pIII leader peptidase cleavage site, and the Acc65 I/Kpn I site in the multiple cloning 
site (MCS) was deleted. Random peptide libraries are constructed by annealing an 
extension primer to a synthetic oligonucleotide encoding the random peptide library 
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and a portion of the pIII leader sequence, extending with DNA polymerase, and 
digesting with Acc65 I and Eag I (Noren and Noren, 2001) (Figure 2.2.). The 
resulting cleaved duplex is inserted into M13KE which has been digested with the 
same enzymes. M13KE and the insert extension primer are supplied with the Ph.D.-
C7C™ Phage Display Peptide Library Kit. 
 Figure 2.2: Restriction map of M13KE (Noren and Noren, 2001). 
The randomized segment of the Ph.D.-C7C™ Phage Display Peptide Library is 
flanked by a pair of cysteine residues, which are oxidized during phage assembly to 
a disulfide linkage, resulting in the displayed peptides being presented to the target 
as loops. (Figure 2.2.) The randomized peptide sequences in the library is 
expressed at the N-terminus of the minor coat protein pIII, resulting in a valency of 5 
copies of the displayed peptide per virion. The first randomized position in the Ph.D.-
C7C library is preceded by Ala-Cys. The library contains a short linker sequence 
(Gly-Gly-Gly-Ser) between the displayed peptide and pIII. 
 2.1.3. Target Substrate 
Synthetic HA powder with specific density of 3.0556 g/cc, average particle size of 
287.520 μm, surface area of 10.57 m2/g and surface charge of –19.9 mV was used 
as target substarte (Figure 2.3.). The powder was obtained from Ivan Transevica 
Institute, Department of Materials Science, Ukraine.  
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Figure 2.3: (a) SEM image of synthetic HA powder used as target substrate. (b) 
XRD pattern of the synthetic HA powder used as target substrate 
2.1.4. Solutions & Medias 
2.1.4.1. Luria Bertani (LB) Medium 
10 g tryptone (Acumedia), 5 g yeast extract (Acumedia), 5 g NaCl (Riedel-de-Haen) 
were dissolved in distilled water and completed up to 1 lt. The pH was adjusted to 
7.0-7.5 with 10 M NaOH and sterilized for 15 min. under 1.5 atm at 121 ˚C. The 
medium was stored at room temperature. 
2.1.4.2. LB Agar Medium 
10 g tryptone (Acumedia), 5 g yeast extract (Acumedia), 5g NaCl (Riedel-de-Haen), 
15 g bactoagar (Acumedia) were dissolved in distilled water and completed up to 1lt 
The pH was adjusted to 7.0-7.5 with 10 M NaOH and sterilized for 15 minutes under 
1.5 atm at 121˚C. Following autoclaving, tetracycline solution (Sigma) (final 
concentration of 10 μg/ml) and X-gal/IPTG solution (final concentration of 40 μg/ml) 
(Fermentas/Sigma) were added when the temperature of the medium was cooled 
down to 45-50 ºC. The medium was shaken properly and poured into the plates by 
avoiding any bubble formation (3.5 ml for 60mm plates and 15 ml for 100mm 
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plates). After the medium was solidified in the plates, they were turned upside down 
and stored at 4 ˚C and protected from light for later use. 
2.1.4.3. Top-Agar Medium 
10 g tryptone (Acumedia), 5 g yeast extract (Acumedia), 5 g NaCl (Riedel-de-Haen), 
1 g MgCl2 (Riedel-de-Haen), 9 g LMP (Low Melting Point) agarose (Acumedia) were 
dissolved in distilled water and completed up to 1 lt and sterilized for 15 minutes 
under 1.5 atm at 121 ˚C. The medium was stored at room temperature and melted 
in microvawe as needed to pour onto the LB agar plates.  
2.1.4.4. ER2738 Overnight Culture 
5 ml LB solution containing 1 mM MgCl2 and tetracycline, was inoculated with E. coli 
ER-2738 stock (from -80°C). The culture was left in the shaker overnight at 37°C, 
200 rpm.  
2.1.4.5. Tetracyline-HCl Stock Solution 
20 mg/ml tetracycline-HCl (Sigma) was dissolved in distilled water. The solution was 
stored at -20°C and protected from light.  
 2.1.4.6. Xgal/ IPTG Stock Solution 
1.25 g IPTG (isopropyl β-D-thiogalactoside) (Sigma) and 1 g Xgal (5-Bromo-4-
chloro-3 indolyl-β-D-galactoside) (Fermentas) were dissolved in 25 ml Dimethyl 
formamide (Riedel-de-Haen). The solution was stored at -20°C and protected from 
light.  
2.1.4.7. Detergent Stock Solution 
20 % (w/v) Tween 20 (Riedel-de-Haen) and 20 % (w/v) Tween 80 (Merck) were 
mixed and dissolved in 20 ml distilled water.  
2.1.4.8. Glycerol Stock Solution   
80 ml of 100% glycerol (Sigma) was mixed with distilled water up to 100 ml total 
volume to have 80 % glycerol solution. It was sterilized for 15 minutes under 1.5 atm 
at 121˚C and stored at room temperature.  
2.1.4.9. MgCl2 Stock Solution 
1M  MgCl2.6H2O (Fisher) was dissolved in distilled water up to 100 ml. and sterilized 
with 0.2 μm single use syringe filter.         
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2.1.4.10. PEG / NaCl Solution 
20% (w/v) polyethylene glycol-8000 (PEG-8000) (Sigma), 2.5 M NaCl (Sigma) were 
prepared in distilled water up to 100ml and sterilized for 15 min under 1.5 atm at 
121˚C. The solution was stored at room temperature.  
2.1.4.11. PC Buffer (Potassium Phosphate-Sodium Carbonate Buffer) 
PC Buffer (no detergent): 55 mM KH2PO4 (Fisher), 45 mM Na2CO3 (Fisher), 200 
mM NaCl (Sigma) were prepared in distilled water and the solution was sterilized by 
0.2 μm single use syringe filter. The pH was adjusted to 7.2-7.5. 
PC Buffer (0.02% detergent): 55 mM KH2PO4 (Fisher), 45 mM Na2CO3 (Fisher), 
200 mM NaCl (Sigma), 0.5 ml detergent stock solution were prepared in distilled 
water and the solution was sterilized by 0.2 μm single use syringe filter. The pH was 
adjusted to 7.2-7.5.   
PC Buffer (0.1% detergent): 55 mM KH2PO4 (Fisher), 45 mM Na2CO3 (Fisher), 200 
mM NaCl (Sigma), 2.5 ml detergent stock solution were prepared in distilled water 
and the solution was sterilized by 0.2 μm single use syringe filter. The pH was 
adjusted to 7.2-7.5.   
PC Buffer (0.5% detergent): 55 mM KH2PO4 (Fisher), 45 mM Na2CO3 (Fisher), 200 
mM NaCl (Sigma), 12.5 ml detergent stock solution were prepared in distilled water 
and the solution was sterilized by 0.2 μm single use syringe filter. The pH was 
adjusted to 7.2-7.5.  
Note: PC buffer can not be sterilized by autoclaving because CO3- ions are 
converted to CO2 due to high pressure during the autoclave. This conversion causes 
an increase in pH up to 10. 
2.1.4.12. Elution Buffers  
Elution buffer I: 0.2 M glycine (Merck) and 1mg /ml BSA (Sigma) were dissolved in 
distilled water and pH was adjusted to 2.2 with 10 M HCl and 0,1M HCl. The solution 
was sterilized by 0.2 μm single use syringe filter. 
Elution buffer A:  0.2 M glycine (Merck) and 2 mg /ml BSA (Sigma), 0.02% SDS 
were dissolved in distilled and pH was adjusted to 2.2 with 10 M HCl and 0.1 M HCl. 
The solution was sterilized by 0.2 μm single use syringe filter. 
Elution buffer B: 1 M NaCl (Riedel-de-Haen), 100 mM DDT (Sigma), 7 mM TCEP 
(Sigma), 100 mM ME were dissolved in distilled water.  
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Elution buffer II: Elution buffer A and B were mixed at 1:1 ratio and the solution 
was sterilized by 0.2 μm single use sterile syringe filter. 
2.1.4.13. Tris Buffer 
5% Casein (Sigma), 10 mM Tris-base (Merck), 150 mM NaCl, 1% tween 20 (Riedel-
de-Haen) were dissolved in 0.1 M NaOH. pH was adjusted to 8.2. 
2.1.4.13. TBE (Tris / Borate / EDTA) Solution 
10X TBE buffer was prepared by dissolving 108 g tris-base (Merck), 55 g boric acid 
(Riedel-de-Haen.) and 4 % (v/v) 0.5M EDTA (Merck) in distilled water. pH was set to 
8.0.  
2.1.5. Laboratory Equipments 
Autoclave: Yamato sterilizer SE 510. 
Electronic balance: Denver Toledo AB 54 
Centrifuge: Sorvall RC 5B Plus Kendro Laboratory Products Eppendorf Centrifuge 
5415D 
Centrifuge rotors: SA-600, SLA-1500, SH-3000, PN-11779. 
Deep freezes and refrigerators: Heto Polar Bear 4410 ultra freezer, JOUAN 
Nordic A/S, catalog# 003431.  
Deionized water system: Millipore Milli Q Synthesis A 10  
Fluorescence microscope: Nikon Eclipse TE 2000-U 
Glassware: Technische Glaswerke Ilmenau GmbH. 
Ice machine: Cornelius Ice Systems 
Incubators: Quincy Lab. Inc. Model 10-14 Incubator VWR 1310  
Laminar flow cabinet: Airclean 600 PCR Workstation ISC Bioexpress 
Orbital shaker: Innova 3100 Water Bath Shaker New Brunswick Scientific 
Magnetic stirrer: AGE 10.0164, VELP Scientifica srl.: ARE 10.0162, VELP 
Scientifica srl. 
Automatic pipettes: Pipetteman 1-20-200-1000-5000 ml 
pH meter: MP 220, Mettler Toledo International Inc.: Inolab pH level 1, order# 
1A10-1113,Wissenschaftlich-Technische Werkstätten GmbH & Co KG.  
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PCR cycler: Eppendorf Master Cycler Gradient  
Power supply: EC 250-90, E-C Apparatus 
DNA sequencer: Applied Biosystems 3730XL 
Spectrophotometer: Tecan Safire  
TEM: Philips 420 EM 
Transilluminator: UV Transilluminator 2000, Catalog# 170-8110EDU, Bio-Rad. 
Ultrasonic bath: Branson 1200 
Vacuum Dryer: Eppendorf Vacufuge Vacuum Pump: Vacuum Station, Catalog# 
165-5004, Bio- Rad.  
Vortexing machine: Reax Top, product# 541-10000, Heidolph2.2. 
X-ray diffractometer: PW1820 Diffractometer coupled with PW1830 Generator, 
Philips 
2.2. METHODS 
2.2.1. Biopanning 
Shortly, one panning round consists of 5 main steps: i-incubating the phage peptide 
library with the target substrate, ii-removing the non-specifically or weakly bound 
and unbound phage particles, iii-eluting the specifically-bound phages, iv-amplifying 
the eluted phage, v-selection of single clones and sequencing. The eluted and 
amplified phages can be used for additional panninng rounds to enrich the pool in 
favor of binding sequences. In this study 3 rounds of panning were performed. A 
brief procedure of panning of the phage peptide library against synthetic HA powder 
is given in Figure 2.4. 
2.2.1.1. Cleaning the HA Powder 
Carefully weighed 10 mg powder was suspended in 100 μl distilled water and 900 μl 
of 1:1 CH3OH / CH3COCH3 mixture was added to the suspension. After vortexing 5 
minutes, the suspension was sonicated for 20 minutes in an ultrasonic bath to break 
the powder clusters. Then the suspension was centrifuged at 200 G for 3 minutes 
and the supernatant was removed. The powder was re-suspended in 1 ml 
(CH3)2CHOH and sonicated for 20 minutes. After vortexing 5 minutes, the 
suspension was centrifuged at 200 G for 3 minutes. The supernatant removed and 
the powder was resuspended in 1 ml PC buffer containing 0.5 % detergent. After 
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vortexing 5 minutes, the suspension was sonicated for 60 minutes. After the 
sonication the suspension was quickly vortexed and centrifuged at 200 G for 3 
minutes. The supernatant was removed and the powder was re-suspended in PC 
buffer containing 0.5 % detergent. Then the powder was washed twice with distilled 
water and twice with (CH3)2CHOH. The powder was dried at vacuum. 
 
 
Figure 2.4: Phage display procedure (The sizes are not to scale):  1) Cleaned 
polycrystalline HA powder. 2) Ph.D.-C7C™ Phage Display Peptide Library. 
(Different colors representing different random sequences. 3) The library is 
incubated with the HA powder in potassium PC bufer containing 0.1% detergent. 4) 
Unbound phages are removed by washing with PC buffer containing 0.1% 
detergent. 5) Specifically bound phages are eluted from the surface using elution 
buffers 6) The eluted phage pool is amplified with Eschericia coli ER2738. 7) 
Amplified phages are purified. Amplified and purified phages are used for 8) 
additional panning rounds and 9) after each round the phages are grown on solid 
media and single clones are selected by picking single phage plaques. 10) DNA of 
single phage clones are isolated and sequenced. Since the insert position of the 
random sequences are known, the peptide sequenced displayed on each clone can 
be obtained from the DNA sequences.  
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2.2.1.2. Phage – Peptide Library Incubation With HA Powder  
1 mg of cleaned HA powder was suspended in 990 μl PC buffer containing 0.1 % 
detergent and 10 μl of phage peptide library was added to the suspension. The 
suspension was left overnight at room temperature with constant rotating. The 
detergent in the buffer prevents the non-specific interactions between phages and 
provides the phages to interact with the powder surface individually. 
2.2.1.3. Washing Un-bound Phages 
After overnight incubation with phage peptide library, the suspension was 
centrifuged at 200 G for 3 minutes. The supernatant, containing unbound or non-
specifically bound phages, was transferred to a fresh tube and the powder was re-
suspended in 1 ml PC buffer containing 0.1 % detergent. The suspension was 
rotated for 30 minutes. At this step, non-specifically bound phages are removed 
from the surface. After 30 minutes rotation, the suspension was centrifuged at 200 G 
for 3 minutes. The re-suspending, rotating and centrifuging steps were repeated 11 
times (Figure 2.5.). The supernatant, containing unbound or non-specifically bound 
phages, was collected to a fresh tube at each repeat.  
The washing procedure was the same for each round of panning except for the 4th 
round. At the 3rd round PC buffer containing 0.5% detergent was used instead of 
0.1%, to obtain the strongest binders by making the washing environment harsher.  
 
Figure 2.5: Procedure of washing  
2.2.1.4. Recovery of the Bound Phages  
After washing the powder to remove the un-bound phages, strongly bound pahges 
were recovered from the powder surface. A newly developed physical elution 
method was used beside chemical elution to improve the efficiency of recovery. In 
 26
the chemical elution, phages are removed from the surface by creating a harsh 
environment by low pH elution buffers. In the physical elution, phages are recovered 
by sending ultrasonic waves to the powder suspension and removing the phages 
from the surface physically. The phages must not be kept in the elution buffer longer 
than 15 minutes since the pH of elution buffers are 2.2 and phage particles lose their 
viablity at this low pH. At the end of all elution steps, the powder was resuspended 
in PC buffer and transferred to a fresh E. coli ER2738 mid log culture in order to 
amplify the phages remained on the surface after all elution steps 
2.2.1.5. Chemical Elution 
After the last washing step, the powder was re-suspended in 1 ml of Elution Buffer I 
and rotated for 15 minutes. After 15 minutes rotation the suspension was 
centrifuged at 200 G for 3 minutes. 800 μl of the supernatant was transferred to 50 
ml fresh E. coli ER2738 mid log culture. The incubation of the culture was started 
right after adding the supernatant. The remaining 200 μl of the supernatant was 
neutralized by adding 40 μl Trish Buffer (pH:9.1). Powder was re-suspended in 1 ml 
of Elution Buffer II and rotated for 15 minutes. After 15 minutes rotation the 
suspension was centrifuged at 200 G for 3 minutes. 800 μl of the supernatant was 
transferred to 50 ml fresh E. coli ER2738 mid log culture. The incubation of the 
culture was started right after adding the supernatant. The remaining 200 μl of the 
supernatant was neutralized by adding 40 μl Trish Buffer (pH:9.1). The powder was 
re-suspended in Elution Buffer II and the same procedure was repeated 2 more 
times, resulting in 4 steps of elution. In each step, the supernatant was transferred 
to a fresh E. coli ER2738 mid log culture.  
2.2.1.6. Physical Elution 
After the 4th step of chemical elution, the powder was re-suspended in 1 ml PC 
buffer.  The tube was placed in an ice bath and ultrasonicated using an ultrasonic 
probe at 150 W and 20 kHz (Braunsonic, U. Waves Probe, USA). At the 15th second 
of the sonication, 800 ml of the suspension was collected and centrifuged at 200 G 
for 3 minutes. The supernatant was transferred to a fresh E. coli ER2738 mid log 
culture. The powder was re-suspended in LB media and transferred to a fresh E. coli 
ER2738 mid log culture to amplify the phages remained on the powder after all 
elution steps.  
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2.2.1.7. Amplification of the Recovered Phages 
E. coli ER2738 mid log cultures, which eluted phages were added to, were 
incubated at 37oC for 4 hours with constant orbital shaking at 200 rpm. During this 
time, M13 phage particles infect E. coli cells and new phage particles are produced. 
Phage particles bind to E. coli through the F pilus. After binding to the phage, the 
pilus retracts, bringing the phage particle to the cell surface. There, the N-terminal 
domain (N1) of pIII interacts with the membrane-bound protein, TolA. The single-
stranded DNA (plus strand) of the phage particle enters the bacterial cell through a 
process that is not well-understood, and it is then converted to double-stranded DNA 
(replicative form) by E. coli proteins. Two virally encoded proteins, pII and pX, are 
involved in rolling-circle amplification of the double-stranded viral genome, which 
leads to the production of plus-strand copies of the phage DNA. Such progeny 
molecules are then coated by the single-strand DNA binding protein, pV. The DNA-
protein complex interacts with the export machinery (pI, pIV, pXI, and thioredoxin), 
which simultaneously assembles and secretes viral particles using a pool of phage 
coat proteins that have already been inserted into the inner membrane. Finally, the 
viral particle is released from the cells, without killing them, and pV is recycled. 
(Figure 2.6.) The cultures may not be incubated longer than 4.5 hours since longer 
incubation periods will cause mutations in the phage genome causing the change or 
loss of the displayed peptide. 
2.2.1.8. Purification of Amplified Phages  
At the end of 4 hours of growth period, E. coli - phage cultures were transferred into 
250 ml sterilized polypropylene centrifuge tubes. The cultures were centrifuged at 
8,000 rpm for 10 min. At this step the cells are spinned down and the phage 
particles remain in the supernatant. The supernatants were transferred to a fresh 
250 ml sterilized polypropylene centrifuge tube. 8.33 ml of PEG / NaCl solution was 
added to the supernatant and was left overnight at 4 0C. At this step the phage 
particles are precipitated out from the solution. After overnight waiting, the tubes 
were centrifuged 8,000 rpm for 10 minutes. Supernatants were discarded and phage 
pellets were resuspended in 5 ml PC buffer. The tubes were centrifuged at 8,000 
rpm for 10 minutes. At this step any remaining E.coli cells are spinned down. 
Supernatants were transferred into 50 ml sterilized polypropylene centrifuge tubes. 
0.833 ml of PEG / NaCl was added to the solution to precipitate phage and the 
solution was kept at 4 0C for 2 hours. Tubes were centrifuged at 10,000 rpm for 10 
minutes. Supernatants were discarded and phage pellets were resuspended by in 1 
ml PC buffer. Tubes were centrifuged at 10,000 rpm for 10 minutes and 
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supernatants were transferred into sterilized microfuge tubes. 0.166 ml of PEG / 
NaCl solution was added to the microfuge tubes to precipitate phage and the tubes 
were vortexed for 5 sec, and kept at room temperature for 10 minutes. Tubes were 
centrifuged at 13,500 rpm for 1.5 minutes to get the compact phage. Supernatants 
were discarded and phage pellets were re-suspended with 0.2 ml PC buffer by 
pipetting gently. The tubes were centrifuged at 13,500 rpm for 1.5 minutes. 
Supernatants, containing ~1011 pfu M13, were transferred into fresh sterilized 
microfuge tubes, labeled properly and stored at 40C.  
 
Figure 2.6: Life cycle of M13 (Kehoe and Kay, 2005) 
2.2.2. Selection of Single Colonies - Blue- White Screening 
After purifying the phages from each round, single colonies were selected by blue-
white display. ER2738 strain of E.coli lacks the lac Z α gene. By the infection of the 
M13mp 19 phage, carrying the lacZ α gene, the ER2738 cells can produce 
competent β-galactosidase. X-gal is a chromogenic substrate for β-galactosidase. A 
blue color forms when X-gal is hydrolized by β-galactosidase so blue phage plaques 
form on X-gal / IPTG containing plates by the metabolism of X-gal.   
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 2.2.2.1. Preparation of mid-log E. coli Cultures 
2 ml media was prepared by adding 4 μl of 1M MgCl2 and 2 μl of tetracycline stock 
solution to LB media. 5 μl of fresh E. coli overnight culture was added to the media 
and the culture was incubated at 37oC untill the OD reached to 0.5. 
 
2.2.2.2. Plating Cell-Phage to Solid Media 
Several dilutions of the phages were prepared prior to screening in order to obtain 
single plaques. The dilutions were prepared in a standart 96 well ELISA plate. 90 μl 
PC buffer was put into the first well of the plate. 180 μl PC buffer was put into the 
other wells. 10 μl phage stock solution was added into the first well resulting 10-1 
dilution. Phage and PC buffer were mixed by pipetting. 20 μl sample was taken from 
the first well and put into the second well to have totally 200 μl of solution resulting 
10-2 dilution level of the phages. The remaining serial dilutions were done the same 
way. (Figure 2.7.) 
 
Figure 2.7: Making the serial dilutions on the Elisa plate 
Overnight culture of ER2738 was prepared one night before plating the phages. 
Previously prepared LB Agar plates containing X-Gal / IPTG were brought to room 
temperature. Top agar media was melted in a 50oC water bath. 20 μl of diluted 
phage solution was added to 180 μl LB solution containing E. coli cells with OD600 ~ 
0.5 resulting in another 10 times dilution of the phage solution making the final 
dilution 10-3. The phage-cell mixture was added to warm LB agar (0.5 μl for 60 mm 
Petri dishes and 3.5 μl for 90 mm Petri dishes) in 15 ml falcon tubes and vortexed. 
The mixture was poured onto the LB plates and waited for 5-10 min for the 
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solidification of the top agar. After the top agar froze, all Petri dishes were turned 
upside down and incubated at 37oC for 8-14 hours. Turning the plates upside down 
provides formation of single phage plaques. 
2.2.2.3. Phage Titers for Each Round 
At the end of the each round, phage titers was estimated by blue-white screening. 
After single phage plaques were obtained, the colonies were counted on the plates 
and the titers of the phages were approximately calculated multiplying with the 
dilution factor.  
2.2.2.4. Preparation of Glycerol Stock of Phage  
After single phage plaques were obtained, plagues were picked and kept in glycerol 
for sequencing and further analysis. The plaques were picked by a sterile pipette tip 
and placed into 200 μl PC buffer containing 0.02 % detergent. Then the buffer was 
kept at 60oC for 45 minutes to dissolve any residual LB Agar on the plaque. Then 
glycerol stocks were prepared for long storing of the phage clones. 60 μl sterilized 
80% glycerol solution was put into each well of a fresh 96-well plate. Then 50 μl of 
single phage plaque dissolved in PC buffer was added into glycerol, resulting a 
~50% glycerol stock. The stocks were kept at -80oC 
2.2.3. Characterization of the Phage Clones – DNA Sequencing  
For the sequencing of the individual phage cones, DNA of each clone was isolated. 
Commercially available QIAprep ® Spin M13 kit (QIAGEN, Catolog #27704) was 
used for the isolation of M13 ssDNA. First, the phages were amplified for DNA 
isolation. 50 μl from each individual phage plaque was taken from the glycerol stock 
and added into 2 ml E. coli ER2738 mid-log culture in a 2ml microfuge tube. Phages 
were amplified for 4 hours at 37oC. At the end of the 4 hours, microfuge tubes were 
centrifuged at 5000 rpm for 15 min at room temperature. Supernatant containing 
M13 bacteriophage was transferred into a fresh reaction tube without disturbing the 
pellet which contains the cells. Any carryover of bacterial cells will result in 
contamination of the M13 ssDNA with bacterial chromosomal DNA or double-
stranded bacteriophage RF DNA. Buffer MP was added at a 1/100 ratio to the 
supernatant in the reaction tube and was mixed by vortexing. The mixture was 
incubated at room temperature for at least 2 minutes. During this step, 
bacteriophage particles were precipitated from the culture medium. A QIAprep spin 
column was placed in a fresh 2 ml microcentrifuge tube and 0.7 ml of the 
precipitated phage was transferred to the QIAprep spin column. Reaction tube was 
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centrifuged for 15 s. at 8,000 rpm and the flow through collected at the bottom was 
discarded. At this step, intact bacteriophage was retained on the silica-gel 
membrane of the spin column. This step was repeated until all of the precipitated 
phage was passed through QIAprep spin column. 0.7 ml MLB buffer was added on 
the spin column for M13 lysis and was and centrifuged for 15 seconds at 8,000 rpm. 
This step creates appropriate conditions for binding of the M13 ssDNA to the 
QIAprep silica-gel membrane. Another 0.7 ml MLB buffer was added to the spin 
column and incubated for 1 minute at room temperature to lyse the bacteriophage 
completely. Spin column was centrifuged for 15 seconds at 8,000 rpm. 0.7 ml Buffer 
PE was added to the spin column and the column was centrifuged for 15 seconds at 
8,000 rpm to remove any residual salt. Buffer PE was discarded from collection tube 
and the spin column was centrifuged for 15 seconds at 8,000 rpm to remove 
residual buffer PE. It is important not to dry the spin column membrane with quick 
microcentrifugation steps since any residual ethanol carried over will affect the 
subsequent PCR steps. 
 
Figure 2.8 : M13 ssDNA isolation procedure (QIAGEN, Catolog #27704). 
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The spin column was placed in a fresh 1.7 ml microcentrifuge tube. 100 μl Buffer EB 
(10 mM tris.Cl, pH 8.5) was added to the center of the column membrane to elute 
the ssDNA from the membrane. After 10 min of incubation at room temperature, the 
tube was centrifuged for 30 seconds at 8,000 rpm to collect the isolated ssDNA. 
2.2.3.1. PCR Conditions for DNA Sequencing 
PCRs were done at a total volume of 10 µl in 0.2 ml PCR reaction tubes. Big dye ® 
terminator v3.1 cycle sequencing Kit (Applied Biosystems) was used for the 
sequencing PCRs.   
Table 2.1: PCR conditions used for DNA sequencing 
PCR ingredients Amount 
Big dye reaction mix* 1µl 
5X sequencing buffer / ddH2O 3 µl 
Template ssDNA 2 µl (150 ng) 
Primer (-96 sequencing primer) * 3.2 µl (3.2 pmol) 
dH2O   0.8 µl 
Total volume  10 µl 
* –96 gIII sequencing primer (5´- HOCCC TCA TAG TTA GCG TAA CG –3´, 100 
pmol, 1 pmol/μl) was supplied with the New England Biolabs Ph.D.-C7C™ Phage 
Display Peptide Library Kit 
PCR conditions for cycle sequencing were as follows; 95 ºC – 2 minutes, 95 ºC – 10 
minutes, 55OC – 10 minutes 60OC – 4minutes. The reaction was run for 35 cycles. 
2.2.3.2. Purification of PCR Product  
2 μl of 3M sodium acetate (pH 4.6) and 50 μl 95 % ethanol were mixed for each 
sample. 52 μl of this mixture was added into each PCR product and samples were 
incubated on ice for 30 minutes. After incubation, samples were centrifuged for 30 
minutes at 14000 rpm. Supernatant was discarded and DNA pellet was washed with 
250 μl cold ethanol. Samples were centrifuged for 30 minutes at 14000 rpm. 
Residua ethanol was discarded by evaporating at 95oC. DNA was re-dissolved in 20 
μl di-formamide. Samples were denatured by keeping at 95oC and then at -20oC for 
5 minutes. ABI 3100 Avant (PE, Applied Biosystem, CA) automated sequencer was 
used for DNA sequencing. 
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 2.2.4. Characterization of the Phage Clones – Immunofluorescence 
Microscopy  
After obtaining the amino acid sequences displayed on phage clones by DNA 
sequencing, immunofluorescence microscopy was done to determine the binding 
strength of the each clone. The same powder substrate used for the phage display 
selection was used for immunofluorescence microscopy. First the phage clone and 
the powder was incubated. Then the phages on the powder were labeled with Anti-
M13 IgG and Anti M13 IgG was labeled with FITC-Anti IgG Fab conjugate. Then the 
powder was checked under the microscope. (Figure 2.9.) 
2.2.4.1. Labeling  
1 mg of previously cleaned HA powder was suspended in 990 μl PC buffer 
containing 0.1 % detergent. Then 10 μl phage was added to the suspension from a 
1013 PFU/ml in PC buffer containing 0.1 % making a final phage concentration of 
1011 PFU/ml. The phage and powder suspension was incubated overnight at room 
temperature with constant rotating. After the overnight incubation, primary antibody 
(Anti M13 IgG) and secondary antibody (Anti IgG Fab – Alexa-Fluor conjugate) 
complex was prepared by mixing at 1:5 ratio and incubating 30 minutes. Anti M13 
IgG binds specifically to the g8p (major coat protein) of the phage and the Alexa-
Fluor – Anti IgG conjugate binds to the Anti M13 IgG. Therefore, the phage particles 
become observable under fluorescence light. While the dye mixture is being 
prepared, overnight incubated phage-powder suspension was centrifuged at 1,000 
rpm for 1.5 minutes. The supernatant was discarded and the powder was 
resuspended in PC buffer containing 0.1 % detergent. The suspension was rotated 
for 15 minutes and centrifuged again at 1,000 rpm for 1.5 minutes and the 
supernatant was discarded. The powder was resuspended in 497 μl PC buffer 
containing 0.1 % detergent and 3 μl of the dye mix was added to the suspension. 
The tube was covered with aluminum folio to protect the fluorescent dye from the 
light and was incubated for 30 minutes. At the end of the 30 minutes the suspension 
was centrifuged at 1,000 rpm for 1.5 minutes and the supernatant was discarded. 
The suspension was washed three times with PC buffer containing 0.1 % detergent. 
At the last washing, the supernatant was discarded and the powder was re-
suspended in 20 ml of PC buffer containing 0.1 % detergent. Then the suspension 
was transferred on a clean microscope slide and checked under a Nikon Eclipse TE 
2000-U microscope.  
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 Figure 2.9: Labeling procedure for fluorescence microscopy 
2.2.4.2. Calculation of the Surface Coverage 
The approximate percent binding affinity of the phages were calculated using 
MetaMorph ® Imaging System Ver. 6.3.  First approximate surface area of the 
powder in bright field image was calculated using the software. Then the area of the 
emitted fluorescence light was calculated with the same way. Then the percentages 
were compared and the percent surface coverage of the phages was calculated. 
The phages were grouped as strong, moderate and weak binders according to their 
surface coverage. 
2.2.5. Characterization of the phage clones – ELISA  
1 mg of previously cleaned HA powder was suspended in 990 μl PBS buffer 
containing 2% BSA. Then 10 μl phage was added to the suspension from a 1013 
PFU/ml in making a final phage concentration of 1011 PFU/ml. The phage and 
powder suspension was incubated for 2 hours at room temperature with constant 
rotating. After the incubation, phage-powder suspension was washed 3 times with 
200μl PBS buffer containing 0.05% detergent. After the washing, the powder was 
re-suspended in 200μl PBS buffer containing 2% BSA. Then 0.4μl HRP-AntiM13 
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antibody conjugate was added to the suspension (Amersham Biosciences, USA) 
and incubated for 30 minutes at room temperature with constant rotating. After the 
incubation, the powder was washed for four times with 200μl PBS buffer containing 
0.05% detergent After the washing, the powder was re-suspended in 200μl PBS 
buffer containing 0.05% detergent. Enzymatic reaction was started by adding 100μl 
TMP (1-step TMP-ELISA, Catalog# 34022, Pierce) to the powder suspension. 
Reaction was ended after 2 minutes by adding 100μl 1M H2SO4. The color change 
was measured with automated multiplate reader (Tecan Trading AG, Switzerland) at 
450 nm wavelength. (Figure 2.10) 
 
 
 
Figure 2.10: ELISA protocol 
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2.2.6. in vitro Mineralization in the Presence of Binder Phages 
An alkaline phosphatase (AP) mediated mineralization system was used for in vitro 
mineralization experiments. In this system Ca+2 needed for the mineralization is 
provided exogenously by dissolving CaCl2. The PO4-3 is provided by e hydrolysis of 
an organic phosphate compound by AP. Here, β-Glyserophosphate was used as the 
organic phosphate compound. When PO4-3 is released to the solution, Ca+2 and 
PO4-3 ions form the Ca/P structure (Figure 2.11.) 
 
 
Figure 2.11: AP mediated mineralization reaction 
2.2.6.1. Mineralization Media 
Mineralization media was prepared by dissolving 24 mM CaCl2 and 14.4 mM β-
Glycerophosphate (β-GP) in 25 mM Tris-HCl buffer (pH:7.4). 2X media was 
prepared, filter sterilized and kept at 4oC. The media containing hydroxyapatite 
binding phages were simply prepared by adding proper amount of phage stock 
solution to the media stock and completing the final concentration to 1X. 
2.2.6.2. Mineralization Reaction 
The reactions were run in a standard 96 well plate. Mineralization solutions 
containing no phage, MG-49 clone MG-63 clone and wt M13 clone were prepared at 
200 ml volume as triplicates. The mineralization reactions were started by adding 
3.5 μg/ml commercial bacterial AP to the solutions. The mineralization reaction was 
continuously monitored 37oC by measuring the absorbance change of the solutions 
due to the mineral formation using an automated multiplate reader (Tecan Trading 
AG, Switzerland). Samples were collected at different time points for SEM and TEM 
analysis.   
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2.2.6.3. SEM and TEM analysis 
2.2.7. in vitro Mineralization in the Presence of Binder Peptides 
The same mineralization media and reaction used in the mineralization experiments 
with phage was used for peptide experiments. The media containing hydroxyapatite 
binding peptides were simply prepared by adding proper amount of peptide stock 
solution to the media stock and completing the final concentration to 1X. The phage 
stocks used in mineralization experiments were prepared in di-H20 to eliminate the 
effect of the free phosphate in PC buffer.  
2.2.7.2. Mineralization Reaction 
Prior to the mineralization experiments, AP activity was measured in the presence of 
no peptide and the binder peptides to check if the AP activity is affected by the 
presence of the peptides. The reactions were run in a standard 96 well plate. 
Mineralization solutions containing no peptide, MG-49 at 0.07 mM and 0.4 mM 
concentrations and MG-63 at 0.07 and 0.4 mM concentrations were prepared at 200 
ml volume as triplicates. The mineralization reactions were started by adding 3.5 
μg/ml commercial bacterial AP to the solutions. The mineralization reaction was 
continuously monitored 37oC by measuring the absorbance change of the solutions 
due to the mineral formation using an automated multiplate reader (Tecan Trading 
AG, Switzerland).  
2.2.7.3. Ca and P Measurements 
10 μl of the media was collected from the same reactions at 0.25, 0.5, 1, 1.5, 2, 3, 4, 
5, 6, 24, 48, 64 and 96 hours. AP was immediately inactivated after sample 
collection by heating up to 90oC for 10 minutes and then cooling down to –20oC, to 
prevent mineral formation after sample collection. The mineralized phase was 
separated by centrifuging at 9500 G for 10 minutes. Supernatant, containing the 
unused Ca and β-GP, was transferred to a fresh tube and the mineral pellet was 
washed three times with di-water to remove excess salts. Then the mineral pellet 
was dissolved by adding 10% nitric acid. The tubes were kept under constant 
shaking for 5 minutes to ensure that all of the powder was dissolved.  
For the calcium measurements, a standard curve was prepared with known 
concentrations of Ca+2. The samples were neutralized by 0.1M Tris buffer (pH: 9.1). 
Then 5 ml of dissolved powder was taken and added to the reaction mix of the Ca 
assay kit (QuantiChrome TM Calcium Assay Kit – Bioassays, USA). The absorbance 
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change was measured using an automated multiplate reader (Tecan Trading AG, 
Switzerland).  
For the phosphate measurements, a standard curve was prepared with known 
concentrations of PO4-3. The samples were neutralized by 0.1M Tris buffer (pH: 9.1). 
Then the phosphate concentration was measured using phosphate assay kit. 
(PiPer™ Phosphate Assay Kit - Invitrogen Corporation, USA).  
2.2.7.4 SEM and TEM Analysis 
Mineralized phase for the case of no peptide, MG-63, and MG-49 were collected at 
0.5, 1.5, 2.5, 28 and 96 hours for TEM and SEM analysis. 10 μl sample was 
collected and placed onto a carbon coated TEM grid. The TEM grid was air dried for 
1 minute at room temperature. After 1 minute, liquid on the TEM grid was carefully 
blotted away using a filter paper. Then the TEM grid was vacuum-dried at 60oC for 2 
hours and stored in a desiccated container.  TEM and SEM analysis were performed 
on the same samples collected on the TEM grid.  
SEM was performed at 10kV using a JSM 7000 (JEOL, Japan) in secondary 
electron imaging mode, and TEM imaging and diffraction were performed at 120kV 
using an EMS 420T (Philips, Netherlands). 
2.2.7.5. Kinetic Analysis of the Mineralization Reaction 
The kinetics of the mineralization reactions in the presence of no peptide and 
hydroxyapatite binding peptides were calculated using the Ca and P measurements. 
First 6 hours data of the reactions were used for the calculations. The calculations 
were made assuming a 1st order reaction.  
Amorphous to crystalline transformation rate was calculated by simply dividing the 
Ca+2 concentrations to the PO4-3 concentrations for a given time point. The Ca/P 
ratio was plotted for the first 6 hours. 
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3. RESULTS AND DISCUSSION 
Synthetic hydroxyapatite powder (HA) was used as substrate for the selection of 
HA-specific 7-aminoacid polypeptides from constrained PhD-7 phage display library. 
Following the biopanning studies, we have analyzed all sequences in terms of their 
amino acid content to search for any trend along the sequences or any convergence 
to a specific sequence and deduced their and their physicochemical properties. In 
the experimental binding characterization, immunolabelling fluorescence microscopy 
technique was applied to test the binding strength and the specificity of each 
sequence.  
The selected peptides were categorized according to their binding strength mainly in 
three groups as good, moderate or weak binders. Next, one of strong and the weak 
HA binders were selected for investigating their effect in vitro biomineralization 
studies. We have utilized an enzyme mediated reaction to follow the peptide effect 
on mineral formation via kinetic and morphological analysis. 
3.1. Biopanning – Phage Display Selection 
We have performed 3 biopanning rounds, total of 290 single phage clones were 
isolated. 56 of these clones were randomly selected for characterization (18 clones 
from the 1st round, 19 clones from 2nd and 3rd rounds).  
3.2. Characterization of the Phage Clones 
3.2.1. Determination of Binding Affinity to Hydroxyapatite Powder 
We have used immunofluoresence microscopy and ELISA assay to characterize the 
randomly selected 56 sequences in terms of their affinity from three rounds of 
biopanning. Out of 56 sequenced clones, 12 clones were characterized as strong 
binder, with a surface coverage higher than 40%, 28 clones were characterized as 
moderate binder, with a surface coverage between 35% and 10%, and 16 clones 
were characterized as weak binder with a surface coverage lower than 10% by 
immunofluorescent microscopy. Examples of immunofluorescent microscopy and 
ELISA results are shown in Figure 3.1.  and Figure 3.2. No binding was observed 
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when wild type M13 bacteriophage was incubated with hydroxyapatite powder, 
indicating that there was no background binding of phage coat proteins.  
Amino acid sequences, binding affinities and the physicochemical properties of the 
characterized clones are listed on Table 3.1., Table 3.2. and Table 3.3.  
Binding affinity characterizations showed that 8 of the 12 strong binders were 
selected in the 3rd round of panning, likewise 11 of 16 weak binders were selected in 
the 1st round of panning, indicating that strong binding clones were enriched in 
additional panning rounds (Figure 3.3.). 
 
Figure 3.1: Bright field and fluorescent images of MG-49, MG-63 and wt - M13 
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Figure 3.2: Relative binding affinities of MG-49, MG-63 and WT-M13 to 
hydroxyapatite determined by ELISA. 
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Figure 3.3: Percent distribution of strong, moderate and weak binders obtained from 
each round 
3.2.2. Statistical Analysis of Amino Acids 
Distribution of amino acids throughout the selected peptides was determined by 
calculating the occurrence percentage of amino acids. However, since distribution of 
amino acids are not the same in the library, relative abundances of amino acids 
were calculated by comparing the occurrence of amino acids in the library and in the 
selected binders. The calculation was made by dividing the difference between the 
distribution of an amino acid in the binder set and in the library to the distribution in 
the library. ([distribution in the binder set – distribution in the library] / distribution in 
the library) Relative abundances of amino acids among all sequences are shown in 
Figure 3.1. , Figure 3.2., Figure 3.3. and Figure 3.4. 
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Relative abundance calculations showed that Asp, Gln, His and Phe were over-
expressed among all sequences. Relative abundances among strong, moderate and 
weak binders were also similar except for that Asn was over-expressed only among 
strong binders.  
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Figure 3.4: Relative abundance of amino acids among all selected sequences. 
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Figure 3.5: Relative abundance of amino acids among strong binders. 
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Figure 3.6: Relative abundance of amino acids among moderate binders. 
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Figure 3.7: Relative abundance of amino acids among weak binders. 
 
3.2.3. Physicochemical Analysis 
Isoelectric point (pI) and molecular weight (MW) of the selected sequences was 
calculated by ExPasy ProtParam tool. (http://www.expasy.org/tools/protparam.html). 
Net charges of the peptides were calculated by subtracting the number of basic 
residues (Asp + Glu) from the number of acidic residues (Arg + Lys). The 
physicochemical properties of the strong, moderate and weak binding sequences 
are listed on Table 3.1., Table 3.2. and Table 3.3.  
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Physicochemical analysis revealed that most of the strong binders were carrying at 
least 1 charged amino acid while the number of sequences containing charged 
amino acids in weak binders were much less. (Figure 3.7.) This is an important 
distinction since acidic proteins, that are known to bind to hydroxyapatite and 
influence biomineralization, are known to carry polar side chains.  
Table 3.1: Approximate surface coverage and physicochemical properties of 
moderate binders 
 Sequence % Binding MW pI Charge 
MG61 TPPHHQP 40% 812.9 6.61 0 
MG48 HSPSNPS 55% 724.7 6.74 0 
MG101 MHPTHTT 38% 823.9 6.69 0 
MG108 HPATIED 38% 781.8 4.64 -2 
MG107 SGQISLL 36% 716.8 5.24 0 
MG55 SGSPVPN 33% 656.6 5.24 0 
MG102 DNTSDMV 33% 780.8 3.56 -2 
MG105 SSWQRLR 31% 932 12 +2 
MG106 QNKDFQK 31% 906.9 8.59 +1 
MG65 HQESHPP 30% 830.8 5.98 -1 
MG62 PHHHHQP 29% 888.9 7.49 0 
MG110 SNYFAEM 29% 860.9 4 -1 
MG117 QSSHSFL 29% 804.8 6.74 0 
MG116 AINDTNQ 27% 774.7 3.8 -1 
MG68 PTTPNEQ 24% 758.8 4 -1 
MG30 SMKVPSS 22% 734.8 8.47 +1 
MG54 SVEERGS 22% 762.7 4.53 -1 
MG33 NESFTGA 22% 724.7 4 -1 
MG41 YPTQTTD 21% 824.8 4.3 -1 
MG42 IYEVNTE 21% 866.9 4.24 -2 
MG13 SPQTPSR 20% 771.8 9.47 +1 
MG47 SDNTVRY 19% 853.8 5.55 0 
MG27 SMIPPYR 18% 863 8.46 +1 
MG45 VLTPTQS 18% 744.8 5.49 0 
MG60 RPIVHHQ 16% 886 9.76 +1 
MG28 MWRDSKP 16% 919 8.5 +1 
MG103 LSPKPQL 9% 781.9 8.75 +1 
MG12 YPPRSNT 1% 833.9 8.75 +1 
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Table 3.2: Approximate surface coverage and physicochemical properties of strong 
binders 
 Sequence % Binding  MW pI Charge 
MG49 MLPHHGA 75% 761.9 6.69 0 
MG31 TTTPNRA 70% 759.8 9.41 +1 
MG39 PVAMPHW 68% 837 7.17 0 
MG100 NNNYSRH 68% 903 8.75 +1 
MG69 PKDAVPA 66% 698.8 6.26 0 
MG29 PSFDNGF 64% 782.8 3.8 -1 
MG46 QLIPVSN 61% 769.9 5.52 0 
MG52 LTQSDHP 58% 769.8 5.08 -1 
MG16 HQHNMKI 40% 907 8.76 +1 
MG32 RTNQPQK 52% 870.9 11 2 
MG67 DPQYGQH 47% 843.8 5.08 -1 
MG10 NSGSRHH 46% 793.8 9.76 +1 
Table 3.3: Approximate surface coverage and physicochemical properties of weak 
binders 
 Sequence % Binding  MW pI Charge 
MG15 HQTHHPQ 15% 883.9 7.02 0 
MG63 NPGFAQA 8% 703.7 5.52 0 
MG64 GIGQPQA 8% 669.7 5.52 0 
MG19 MIFLRVV 6% 877.1 9.5 1 
MG104 TAHAMLY 6% 805.9 6.4 0 
MG109 HLPIPSA 6% 733.8 6.74 0 
MG20 MGAGRAA 5% 632.7 9.5 1 
MG34 SIHSRDT 4% 814.8 6.46 0 
MG36 TFHKWPS 3% 902 8.44 1 
MG50 STWIPEF 2% 878.9 4 -1 
MG51 PSSPLQS 2% 714.7 5.96 0 
MG58 HLHQQNT 2% 876.9 6.92 0 
MG59 QLQLLQS 1% 828.9 5.52 0 
MG66 RTTPSYH 1% 860.9 8.75 1 
MG118 TTHQEAP 1% 782.8 5.21 -1 
MG11 TGLQNSS 1% 705.7 5.19 0 
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Figure 3.8: Percentage of peptides containing at least 1 charged amino acid among 
strong, moderate and weak binders. 
3.3. in vitro Mineralization 
At the end of the binding characterization, the strongest binding clone, MG-49 
(CMLPHHGAC), with a surface coverage of 75%, and a weak binding clone, MG-63 
(CNPFFAQAC), with a surface coverage of 4% and similar chemical properties with 
MG-49 clone were selected for in vitro mineralization experiments. 
 AP activity measurements were done prior to mineralization experiments. Activity 
measurements revealed no significant change between the AP activity in the 
presence of peptides and no peptide, indicating that the effects were due to the 
presence of the peptides. Activity of AP in the presence of no peptide, MG-49 and 
MG-63 is shown in Figure 3.8. 
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Figure 3.9: Phosphate concentrations released by AP in the presence of no peptide, 
MG-49 and MG-63 peptide. 
3.3.1. Effect of Hydroxyapatite Binding Phages on in vitro Mineralization – 
Absorbance Measurements 
Absorbance measurements revealed no significant difference between the 
absorbance increases in the presence of no phage and binder phages. The onset of 
the absorbance increase was observed around 15-20 minutes in all cases. At the 
end of the 1st hour, no significant difference was observed in the increase of the 
absorbance. (Figure 3.9.) 
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 Figure 3.10: Effect of MG-49 and wt-M13 phage on mineralization measured by 
continuous absorbance measurements by multiplate reader. (inset: 0-180 minutes) 
3.3.2. Effect of Hydroxyapatite Binding Phages on in vitro Mineralization – 
SEM Analysis  
SEM analysis revealed no significant difference in the morphology of the formed 
minerals. Plate-like minerals were formed at the end of 10 days of mineralization in 
each case. The plate-like features formed in the presence of wild type M13 and MG-
49 phage were slightly smaller than the ones formed in the presence of no phage. 
However, no morphological difference between the minerals formed in the presence 
of wild type M13 and MG-49 phage was observed (Figure 3.10.). 
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 Figure 3.11. SEM images of the minerals formed in the presence of no phage (a-b), 
wild type M13 phage (c-d) and MG - 49 phage (e-f) at the end of 3 days and 10 days.  
The possible reason for observing no morphological and kinetic difference in the 
presence of hydroxyapatite phages may be due to the size difference of the phage 
coat proteins and the displayed peptides. Since the size of the displayed peptide is 
much smaller than the coat proteins of M13 phage, the coat proteins may be 
blocking the effect of the displayed peptide even though they do not bind to the 
hydroxyapatite surface. Therefore, instead of using the phages to see the effects of 
the binding peptides, we commercially synthesized the peptide sequence displayed 
on the phage and used directly the peptides in the mineralization experiments. 
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3.3.3. Effect of Hydroxyapatite Binding Peptides on in vitro Mineralization – 
Absorbance Measurements 
The mineralization in the presence of binding peptides was characterized via 
absorbance measurements, Ca-P measurements, SEM and TEM. 
Absorbance measurements showed that the mineralization was effected by the 
presence of the peptides.  In the presence of no peptide, the onset of the 
absorbance increase started at about 10 -15 minutes. In the presence of low 
concentration of both strong and weak binding peptides (0.07 mM), the onset of the 
absorbance was slightly delayed to 15-20 minutes and the increase in the 
absorbance was slightly reduced. There was no significant difference between the 
effect of the MG-49 and MG-63. However at high concentration of peptides (0.4 mM), 
a dramatic change was observed in the absorbance increase. In the case of MG-63, 
the onset of the absorbance was delayed significantly to 35-40 minutes and the 
absorbance was reduced about 1/3 at 90 minutes. The effect was more dramatic in 
the case of 0.4 mM MG-49. At the end of 90 minutes, there was almost no increase 
in the absorbance in the presence of MG-49. (Figure 3.12.a) The appearances of 
the reaction solutions were also consistent with the absorbance measurements. 
There was a fast increase in the turbidity of no peptide reaction. The reaction well of 
MG-49 reaction was still clear at the end of the 90 minutes. The retardation of the 
mineralization was to a lesser extent in the MG-63 reaction. At the end of 28 hours, 
turbidity of all reactions were similar, indicating that sufficient mineralization was 
occurred (Figure 3.12.b)  
0
0.05
0.1
0.15
0.2
0.25
0.3
0 10 20 30 40 50 60 70 80 90
Time (min)
No Peptide
MG49 (0.4 mM)
MG 49
(0.07 mM)
MG 63
(0.07 mM)
MG 63 
(0.4 mM)
A
 82
0
No peptide MG49 MG63
0 
m
in
30
 m
in
90
 m
in
28
 h
rs
0.4 mM
 
ba 
Figure 3.12: Effect of MG-63 and MG-49 on mineralization measured by (a) 
continuous absorbance measurements by multiplate reader and (b) optical images 
of the reaction solutions at different time points. 
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These initial findings indicate that the effects of the peptides are sequence and dose 
specific. However absorbance measurements give rough information about the 
reaction kinetics since it is not too sensitive. Therefore, reaction kinetics was further 
analyzed by calcium and phosphate measurements.  
3.3.4. Effect of HABPs on in vitro Mineralization – Calcium and Phosphate 
Measurements 
The effects of the peptides on mineralization kinetics were further investigated by 
measuring the used Ca and P amounts. The similar inhibition effect observed in 
absorbance measurements was observed with Ca and P measurements too. In the 
presence of no peptide, 75% of the Ca and 90% of the P were already consumed at 
the end of the first 6 hours. In the presence of MG-63, 63% of the Ca and 76% of 
the P was consumed at the end of 6 hours. However, in the presence of MG-49, 
only 25% of the Ca and 35% of the P was consumed in 6 hours. (Figure 3.13. b and 
d)  
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Figure 3.13: Concentrations of consumed Ca between (a) 0-96 hours (b) 0-6 hours 
and consumed P between (c) 0-96 hours and (d) 0-6 hours. 
At the end of 96 hours, all of the Ca and P were used in no peptide and MG-63 
reactions. However in MG-49 reactions about 1 mM Ca and P were not consumed. 
This may indicate that MG-49 may be inhibiting the mineralization by binding to the 
precursor molecules, Ca and P.  
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The reaction rates for the first 6 hours were calculated assuming 1st order kinetics 
using the calcium consumption rates. The reaction rates for no peptide, MG-63 and 
MG-49 were 7.9 x 10-3 / min, 3.9 x 10-3 / min, 1.2 x 10-3 / min, respectively. (Figure 
3.14.) These results show that the mineralization reaction was inhibited about 1/2 in 
the presence of MG-63 and 1/4 in the presence of MG-49 compared to the reaction 
rate in the presence of no peptide. 
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Figure 3.14: Reaction rates of mineralization assuming 1st order reaction kinetics 
based on Ca+2 consumption. 
Lastly, Ca / P ratios were calculated for no peptide, MG-63 and MG-49 reactions at 
given times. At the end of 30 minutes, the Ca / P ratio of all cases were about 1.55 – 
1.6 which is the Ca / P ratio of the amorphous calcium phosphate (ACP, Ca9 (PO4)6). 
However, at the end of the 1st hour, Ca / P rate for no peptide and MG-63 was about 
1.45 while the rate for MG-49 was about 1.37. At the end of 2.5 hour, the rate for 
MG-49 reaction reached to 1.33, which is the Ca / P ratio for octacalcium phosphate 
(OCP, Ca8H2(PO4)6), a precursor of hydroxyapatite, and stabilized for the rest of the 
reaction. However, no peptide and MG-63 reactions reached the same ratio at the 
end of the 4th hour before becoming stable for the rest of the reaction (Figure 3.16.). 
These results indicate that, the peptides not only affect the kinetics of the 
mineralization reaction, but also affect the conversion rate of the mineral from 
amorphous calcium - phosphate to crystalline calcium - phosphate. 
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Figure 3.15: Ca / P ratio of the mineral formed in the presence of no peptide, MG-
63 and MG-49 
3.3.5. Effect of HABPs on in vitro Mineralization – TEM Analysis 
The mineralized phase in all three cases was OCP as determined by electron 
diffraction analysis. TEM analysis showed that at the end of 96 hours, the size of the 
crystals formed in the presence of MG-49 was much bigger (Figure 3.16 a-b) than 
that of formed in the presence of MG-63 (Figure 3.16 c-d) and no peptide (Figure 
3.16 e-f). As seen on Figure 3.16.e, the sizes of the crystals formed in the presence 
of MG-49 were not homogenous. The small crystals observed in no peptide and 
MG-63 cases were observed together with much larger crystals, larger crystals 
being dominant, for MG-49 case. Also in the presence of MG-63, slightly bigger 
crystals were observed compared to no peptide reaction, however, the size 
difference was not as dramatic as MG-49 case when compared to no peptide and 
the number of smaller crystals was dominant throughout the collected samples.  
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Figure 3.16: TEM images of the minerals formed in the presence of no peptide (a-b), 
MG-63 (b-c) and MG -49 (c-d) at the end of 96 hours. The insets in a, c and e are 
the selected area diffraction patterns for the shown minerals. 
3.3.6. Effect of HABPs on in vitro Mineralization – SEM Analysis 
A time wise analysis of morphology was made by SEM. At 30 minutes, globular 
particles were observed in both control and MG-49 reactions (Figure 3.17. a-b). 
However the size of the particles formed in the presence of MG-49 (~100 nm) was 
~5 times smaller than that of formed in the presence of no peptide (~500nm). Also 
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the number of the particles formed in the presence of MG-49 was much less than 
that of formed in the presence of no peptide. At 90 minutes, the sizes of the globular 
features were grown to a similar size in both reactions (~ 1 μm). However, spicular 
features were observed on the particles formed in the presence of MG-49 while the 
particles formed in the presence of no peptides were still smooth. (Figure 3.17. c-d). 
At 2.5 hours, the size of the globular particles formed in the presence of no peptide 
did not change and spicular features appeared on them too. However no more 
globular particles were observed in MG-49 reaction due to the growth of the spicular 
features into plates. (Figure 3.17. e-f). At 28 hours, no change was observed in the 
morphology of the particles formed in the presence of no peptide, while the plates 
formed in the presence of MG-49 grew bigger. (Figure 3.17. g-h). No more 
morphological changes were observed in both reactions after 28 hours (not shown). 
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Figure 3.17: SEM images of the minerals formed in the presence of no peptide and 
MG- 49 collected at 0.5 hour (a-b), 1.5 hours (c-d), 2.5 hours (e-f) and 28 hours       
(g-h). 
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3.4. Effect Mechanisms of HABPs on in vitro Mineralization 
The results obtained in this study demonstrate that combinatorially selected novel 
hydroxyapatite-binding peptides can significantly influence mineral formation and 
growth in vitro. The effect of the strong binding peptide selected for this study, MG-
49, appears to be expressed during both the initial phase and the later stages of the 
mineralization. The reduction in the mineral formation and size at the initial stage of 
the mineralization (Figure 3.17. a-b) may indicate a nucleation inhibition due to 
chelation of Ca+2 or PO4-3 ions by MG-49 peptide, therefore inhibiting the solution 
access of Ca+2 or PO4-3. The Ca+2 and PO4-3 measurements revealed that at the end 
of the 6th our, 75% of the Ca+2  and 90% of the PO4-3 were already consumed in the 
presence of no peptide while only 25% of the Ca+2 and 35% of the PO4-3 was 
consumed in the presence of MG-49. (Figure 3.13. b-d). Therefore, almost all of the 
precursors were consumed in the presence of no peptide resulting in crystals with 
high in the number but small in the size. On the other hand, at the same time point, 
there were still enough amounts of precursors for the growth of formed mineral in 
the presence of MG-49 resulting in crystals with low in the number but large in the 
size.  
Again the Ca+2 and PO4-3 measurements showed that all of the Ca+2 and PO4-3 were 
consumed at the end of 96 hours (Figure 3.13. a-c). This may be due to binding of 
the peptide to the crystal surface instead of the Ca+2 or PO4-3 ions resulting in the 
release of the Ca+2 or PO4-3 ions bound to the peptide as the mineralization 
proceeds. Since the selected have affinity to hydroxyapatite powder, one would 
expect the peptide to have less free energy when bound to the mineral surface; 
therefore, prefer to bind to the crystal surface instead of the Ca+2 or PO4-3 ions as the 
mineralization proceeds.  
TEM and SEM observations of the minerals obtained from MG-49 reaction showed 
that minerals bearing similar morphological characteristics to those obtained from 
control and MG-63 reactions co-exist with large crystals formed only in MG-49 
reaction. These findings are due to that nucleation and growth processes occur at 
the same time during the process. As PO4-3 is released by AP it is consumed for 
both growth of already formed nuclei and formation of new nuclei. Therefore, at the 
end of the reaction, when there are no more precursors left for mineralization, we 
observe large crystals and smaller crystals which couldn’t grow. 
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